These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 22646257

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA, Zervos EE, Strosberg J, Boe BA, Malafa M, Rosemurgy AS, Yeatman TJ, Carey L, Duhaine L, Kvols LK.
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
    Ho AS, Picus J, Darcy MD, Tan B, Gould JE, Pilgram TK, Brown DB.
    AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
    Atwell TD, Charboneau JW, Que FG, Rubin J, Lewis BD, Nagorney DM, Callstrom MR, Farrell MA, Pitot HC, Hobday TJ.
    Cardiovasc Intervent Radiol; 2005 May; 28(4):409-21. PubMed ID: 16041556
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic strategies for neuroendocrine liver metastases.
    Frilling A, Clift AK.
    Cancer; 2015 Apr 15; 121(8):1172-86. PubMed ID: 25274401
    [Abstract] [Full Text] [Related]

  • 9. Neuroendocrine liver metastases.
    Reddy SK, Clary BM.
    Surg Clin North Am; 2010 Aug 15; 90(4):853-61. PubMed ID: 20637952
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience.
    Dejong CH, Parks RW, Currie E, Piris J, Redhead DN, Garden OJ.
    J R Coll Surg Edinb; 2002 Apr 15; 47(2):495-9. PubMed ID: 12018694
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver.
    Gaur SK, Friese JL, Sadow CA, Ayyagari R, Binkert CA, Schenker MP, Kulke M, Baum R.
    Cardiovasc Intervent Radiol; 2011 Jun 15; 34(3):566-72. PubMed ID: 21431978
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metastatic neuroendocrine hepatic tumors: resection improves survival.
    Musunuru S, Chen H, Rajpal S, Stephani N, McDermott JC, Holen K, Rikkers LF, Weber SM.
    Arch Surg; 2006 Oct 15; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnosis and treatment of metastatic disease to the liver.
    Arciero CA, Sigurdson ER.
    Semin Oncol; 2008 Apr 15; 35(2):147-59. PubMed ID: 18396200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.